Annual EBIT
-$72.98 M
-$5.89 M-8.78%
December 31, 2023
Summary
- As of February 7, 2025, JANX annual earnings before interest & taxes is -$72.98 million, with the most recent change of -$5.89 million (-8.78%) on December 31, 2023.
- During the last 3 years, JANX annual EBIT has fallen by -$66.40 million (-1009.44%).
- JANX annual EBIT is now -1835.27% below its all-time high of -$3.77 million, reached on December 31, 2019.
Performance
JANX EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBIT
-$35.84 M
-$22.02 M-159.31%
September 30, 2024
Summary
- As of February 7, 2025, JANX quarterly earnings before interest & taxes is -$35.84 million, with the most recent change of -$22.02 million (-159.31%) on September 30, 2024.
- Over the past year, JANX quarterly EBIT has dropped by -$20.03 million (-126.66%).
- JANX quarterly EBIT is now -2753.66% below its all-time high of -$1.26 million, reached on September 30, 2020.
Performance
JANX Quarterly EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBIT
-$85.96 M
-$20.03 M-30.38%
September 30, 2024
Summary
- As of February 7, 2025, JANX TTM earnings before interest & taxes is -$85.96 million, with the most recent change of -$20.03 million (-30.38%) on September 30, 2024.
- Over the past year, JANX TTM EBIT has dropped by -$10.85 million (-14.45%).
- JANX TTM EBIT is now -6432.07% below its all-time high of -$1.32 million, reached on March 31, 2020.
Performance
JANX TTM EBIT Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBIT Formula
EBIT = Revenue − COGS − Operating Expenses
JANX EBIT Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -8.8% | -126.7% | -14.4% |
| 3 y3 years | -1009.4% | -228.7% | -307.5% |
| 5 y5 years | -1835.3% | -2623.6% | -6432.1% |
JANX EBIT Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -121.6% | at low | -165.7% | at low | -161.1% | at low |
| 5 y | 5-year | -1835.3% | at low | -2753.7% | at low | -6432.1% | at low |
| alltime | all time | -1835.3% | at low | -2753.7% | at low | -6432.1% | at low |
Janux Therapeutics EBIT History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$35.84 M(+159.3%) | -$85.96 M(+30.4%) |
| Jun 2024 | - | -$13.82 M(-31.4%) | -$65.93 M(-9.5%) |
| Mar 2024 | - | -$20.16 M(+24.9%) | -$72.86 M(-0.2%) |
| Dec 2023 | -$72.98 M(+8.8%) | -$16.14 M(+2.0%) | -$72.98 M(-2.8%) |
| Sep 2023 | - | -$15.81 M(-23.8%) | -$75.11 M(-2.9%) |
| Jun 2023 | - | -$20.75 M(+2.3%) | -$77.32 M(+4.7%) |
| Mar 2023 | - | -$20.28 M(+11.0%) | -$73.83 M(+10.0%) |
| Dec 2022 | -$67.09 M | -$18.27 M(+1.4%) | -$67.09 M(+7.7%) |
| Sep 2022 | - | -$18.02 M(+4.4%) | -$62.31 M(+12.9%) |
| Jun 2022 | - | -$17.26 M(+27.5%) | -$55.20 M(+24.9%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$13.54 M(+0.4%) | -$44.19 M(+34.2%) |
| Dec 2021 | -$32.93 M(+400.6%) | -$13.49 M(+23.7%) | -$32.93 M(+56.1%) |
| Sep 2021 | - | -$10.90 M(+74.4%) | -$21.09 M(+84.3%) |
| Jun 2021 | - | -$6.25 M(+173.7%) | -$11.45 M(+51.7%) |
| Mar 2021 | - | -$2.28 M(+38.0%) | -$7.55 M(+14.7%) |
| Dec 2020 | -$6.58 M(+74.4%) | -$1.66 M(+31.8%) | -$6.58 M(+33.6%) |
| Sep 2020 | - | -$1.26 M(-46.6%) | -$4.92 M(+34.3%) |
| Jun 2020 | - | -$2.35 M(+78.6%) | -$3.67 M(+178.6%) |
| Mar 2020 | - | -$1.32 M | -$1.32 M |
| Dec 2019 | -$3.77 M | - | - |
FAQ
- What is Janux Therapeutics annual earnings before interest & taxes?
- What is the all time high annual EBIT for Janux Therapeutics?
- What is Janux Therapeutics annual EBIT year-on-year change?
- What is Janux Therapeutics quarterly earnings before interest & taxes?
- What is the all time high quarterly EBIT for Janux Therapeutics?
- What is Janux Therapeutics quarterly EBIT year-on-year change?
- What is Janux Therapeutics TTM earnings before interest & taxes?
- What is the all time high TTM EBIT for Janux Therapeutics?
- What is Janux Therapeutics TTM EBIT year-on-year change?
What is Janux Therapeutics annual earnings before interest & taxes?
The current annual EBIT of JANX is -$72.98 M
What is the all time high annual EBIT for Janux Therapeutics?
Janux Therapeutics all-time high annual earnings before interest & taxes is -$3.77 M
What is Janux Therapeutics annual EBIT year-on-year change?
Over the past year, JANX annual earnings before interest & taxes has changed by -$5.89 M (-8.78%)
What is Janux Therapeutics quarterly earnings before interest & taxes?
The current quarterly EBIT of JANX is -$35.84 M
What is the all time high quarterly EBIT for Janux Therapeutics?
Janux Therapeutics all-time high quarterly earnings before interest & taxes is -$1.26 M
What is Janux Therapeutics quarterly EBIT year-on-year change?
Over the past year, JANX quarterly earnings before interest & taxes has changed by -$20.03 M (-126.66%)
What is Janux Therapeutics TTM earnings before interest & taxes?
The current TTM EBIT of JANX is -$85.96 M
What is the all time high TTM EBIT for Janux Therapeutics?
Janux Therapeutics all-time high TTM earnings before interest & taxes is -$1.32 M
What is Janux Therapeutics TTM EBIT year-on-year change?
Over the past year, JANX TTM earnings before interest & taxes has changed by -$10.85 M (-14.45%)